

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | snRNA transcription (GO:0009301) | 7.83329557 |
| 2 | positive regulation of B cell differentiation (GO:0045579) | 7.35242070 |
| 3 | B cell proliferation (GO:0042100) | 7.19858032 |
| 4 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 6.74291579 |
| 5 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 6.73844432 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.39837840 |
| 7 | daunorubicin metabolic process (GO:0044597) | 6.12228090 |
| 8 | polyketide metabolic process (GO:0030638) | 6.12228090 |
| 9 | doxorubicin metabolic process (GO:0044598) | 6.12228090 |
| 10 | regulation of B cell differentiation (GO:0045577) | 6.00052381 |
| 11 | positive thymic T cell selection (GO:0045059) | 5.87139370 |
| 12 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 5.77117773 |
| 13 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 5.77117773 |
| 14 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 5.69054766 |
| 15 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 5.64574149 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.07685338 |
| 17 | regulation of germinal center formation (GO:0002634) | 4.71442595 |
| 18 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.65083257 |
| 19 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.65083257 |
| 20 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 4.57956100 |
| 21 | synaptic transmission, dopaminergic (GO:0001963) | 4.47694231 |
| 22 | positive regulation of B cell proliferation (GO:0030890) | 4.41666567 |
| 23 | positive T cell selection (GO:0043368) | 4.39390744 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.38823004 |
| 25 | auditory behavior (GO:0031223) | 4.38212260 |
| 26 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.32787071 |
| 27 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.31974577 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.31574114 |
| 29 | B cell homeostasis (GO:0001782) | 4.23331344 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.22172246 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.18017195 |
| 32 | positive regulation of B cell activation (GO:0050871) | 4.11195111 |
| 33 | prepulse inhibition (GO:0060134) | 4.10335519 |
| 34 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.10276345 |
| 35 | striatum development (GO:0021756) | 4.08653752 |
| 36 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.06980874 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.04184597 |
| 38 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 4.02542772 |
| 39 | regulation of glucocorticoid metabolic process (GO:0031943) | 4.00446288 |
| 40 | negative regulation of bone resorption (GO:0045779) | 3.97501269 |
| 41 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.95867577 |
| 42 | response to auditory stimulus (GO:0010996) | 3.95540791 |
| 43 | vocalization behavior (GO:0071625) | 3.92892858 |
| 44 | startle response (GO:0001964) | 3.92874456 |
| 45 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.90892526 |
| 46 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.89566885 |
| 47 | negative regulation of histone methylation (GO:0031061) | 3.88909058 |
| 48 | presynaptic membrane assembly (GO:0097105) | 3.81119285 |
| 49 | regulation of B cell proliferation (GO:0030888) | 3.76568090 |
| 50 | defense response to protozoan (GO:0042832) | 3.76048227 |
| 51 | vesicle targeting (GO:0006903) | 3.75984198 |
| 52 | behavioral response to cocaine (GO:0048148) | 3.75769711 |
| 53 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.73650574 |
| 54 | response to amphetamine (GO:0001975) | 3.72629988 |
| 55 | neuron-neuron synaptic transmission (GO:0007270) | 3.72575025 |
| 56 | neuron cell-cell adhesion (GO:0007158) | 3.71675796 |
| 57 | cAMP catabolic process (GO:0006198) | 3.69686524 |
| 58 | lymphocyte proliferation (GO:0046651) | 3.68888108 |
| 59 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.68297827 |
| 60 | mast cell degranulation (GO:0043303) | 3.64404792 |
| 61 | mast cell activation involved in immune response (GO:0002279) | 3.64404792 |
| 62 | regulation of fibroblast apoptotic process (GO:2000269) | 3.62649209 |
| 63 | mononuclear cell proliferation (GO:0032943) | 3.61411012 |
| 64 | negative regulation of T cell differentiation (GO:0045581) | 3.61225599 |
| 65 | synaptic transmission, glutamatergic (GO:0035249) | 3.59879182 |
| 66 | presynaptic membrane organization (GO:0097090) | 3.58978376 |
| 67 | regulation of histone H3-K9 methylation (GO:0051570) | 3.57552303 |
| 68 | T cell selection (GO:0045058) | 3.56798116 |
| 69 | cellular extravasation (GO:0045123) | 3.55434212 |
| 70 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 3.54178737 |
| 71 | cyclic nucleotide catabolic process (GO:0009214) | 3.53376080 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.52802485 |
| 73 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.52671334 |
| 74 | G-protein coupled receptor internalization (GO:0002031) | 3.52408991 |
| 75 | mechanosensory behavior (GO:0007638) | 3.51719308 |
| 76 | glutamate receptor signaling pathway (GO:0007215) | 3.49723300 |
| 77 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.47625492 |
| 78 | activation of MAPKKK activity (GO:0000185) | 3.47363569 |
| 79 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.44956537 |
| 80 | thymic T cell selection (GO:0045061) | 3.43747821 |
| 81 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.43376779 |
| 82 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.42892800 |
| 83 | somatic diversification of immunoglobulins (GO:0016445) | 3.41593460 |
| 84 | B cell activation (GO:0042113) | 3.41347797 |
| 85 | drinking behavior (GO:0042756) | 3.40346635 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 3.38819245 |
| 87 | B cell mediated immunity (GO:0019724) | 3.38490036 |
| 88 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.37926260 |
| 89 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.37552672 |
| 90 | cellular response to type I interferon (GO:0071357) | 3.28482468 |
| 91 | type I interferon signaling pathway (GO:0060337) | 3.28482468 |
| 92 | leukocyte proliferation (GO:0070661) | 3.26412458 |
| 93 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.25657602 |
| 94 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.25589170 |
| 95 | postsynaptic membrane organization (GO:0001941) | 3.25583936 |
| 96 | regulation of glutamate secretion (GO:0014048) | 3.24706979 |
| 97 | response to type I interferon (GO:0034340) | 3.24476594 |
| 98 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.23328717 |
| 99 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.22775738 |
| 100 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.22568525 |
| 101 | transmission of nerve impulse (GO:0019226) | 3.20404051 |
| 102 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.19653348 |
| 103 | negative regulation of bone remodeling (GO:0046851) | 3.18198381 |
| 104 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.18000664 |
| 105 | Peyers patch development (GO:0048541) | 3.18000664 |
| 106 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.17746022 |
| 107 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.17746022 |
| 108 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230) | 3.15321561 |
| 109 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.13115156 |
| 110 | sodium ion export (GO:0071436) | 3.12192140 |
| 111 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.11842336 |
| 112 | response to histamine (GO:0034776) | 3.11833437 |
| 113 | membrane raft organization (GO:0031579) | 3.11350205 |
| 114 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.11347334 |
| 115 | negative regulation of B cell apoptotic process (GO:0002903) | 3.09973056 |
| 116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.09531377 |
| 117 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.09071746 |
| 118 | female mating behavior (GO:0060180) | 3.08364365 |
| 119 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.08350333 |
| 120 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.08130429 |
| 121 | regulation of neurotransmitter uptake (GO:0051580) | 3.06564120 |
| 122 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.04004023 |
| 123 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.03297189 |
| 124 | regulation of B cell apoptotic process (GO:0002902) | 3.00819125 |
| 125 | mast cell activation (GO:0045576) | 3.00693117 |
| 126 | response to protozoan (GO:0001562) | 3.00043929 |
| 127 | regulation of B cell activation (GO:0050864) | 2.99381053 |
| 128 | mitochondrion distribution (GO:0048311) | 2.96148912 |
| 129 | protein localization to synapse (GO:0035418) | 2.94380432 |
| 130 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.93477402 |
| 131 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.93477402 |
| 132 | negative regulation of hormone metabolic process (GO:0032351) | 2.93019994 |
| 133 | regulation of female receptivity (GO:0045924) | 2.91864203 |
| 134 | natural killer cell differentiation (GO:0001779) | 2.88742521 |
| 135 | mature B cell differentiation (GO:0002335) | 2.88483373 |
| 136 | behavioral defense response (GO:0002209) | 2.88125214 |
| 137 | behavioral fear response (GO:0001662) | 2.88125214 |
| 138 | long-term synaptic potentiation (GO:0060291) | 2.87849721 |
| 139 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.87084442 |
| 140 | regulation of superoxide anion generation (GO:0032928) | 2.86629943 |
| 141 | visual learning (GO:0008542) | 2.86556587 |
| 142 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.85627367 |
| 143 | positive regulation of type 2 immune response (GO:0002830) | 2.84475302 |
| 144 | hepatocyte apoptotic process (GO:0097284) | 2.84463084 |
| 145 | adaptive immune response (GO:0002250) | 2.83985982 |
| 146 | lymphocyte homeostasis (GO:0002260) | 2.83805542 |
| 147 | macrophage activation involved in immune response (GO:0002281) | 2.83166607 |
| 148 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.83020932 |
| 149 | regulation of synapse structural plasticity (GO:0051823) | 2.80158116 |
| 150 | L-amino acid import (GO:0043092) | 2.80023889 |
| 151 | T cell homeostasis (GO:0043029) | 2.80011514 |
| 152 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.78788668 |
| 153 | gamma-aminobutyric acid transport (GO:0015812) | 2.78602033 |
| 154 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.78520381 |
| 155 | B cell activation involved in immune response (GO:0002312) | 2.78134087 |
| 156 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.77887011 |
| 157 | positive regulation of action potential (GO:0045760) | 2.76634479 |
| 158 | phosphorelay signal transduction system (GO:0000160) | 2.76533340 |
| 159 | negative regulation of cell killing (GO:0031342) | 2.76166035 |
| 160 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.76166035 |
| 161 | long-term memory (GO:0007616) | 2.73639253 |
| 162 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.73501373 |
| 163 | neuronal ion channel clustering (GO:0045161) | 2.73424484 |
| 164 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.72698409 |
| 165 | learning (GO:0007612) | 2.72684393 |
| 166 | associative learning (GO:0008306) | 2.69132830 |
| 167 | regulation of synapse maturation (GO:0090128) | 2.68627833 |
| 168 | glycine transport (GO:0015816) | 2.67620763 |
| 169 | serotonin receptor signaling pathway (GO:0007210) | 2.67562367 |
| 170 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.67431747 |
| 171 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.67235987 |
| 172 | cellular response to interferon-beta (GO:0035458) | 2.66457633 |
| 173 | activation of JUN kinase activity (GO:0007257) | 2.65380185 |
| 174 | positive regulation of Rap GTPase activity (GO:0032854) | 2.65032847 |
| 175 | neuronal action potential (GO:0019228) | 2.62503175 |
| 176 | visual behavior (GO:0007632) | 2.62457549 |
| 177 | regulation of postsynaptic membrane potential (GO:0060078) | 2.62052959 |
| 178 | positive regulation of amino acid transport (GO:0051957) | 2.61651297 |
| 179 | negative regulation of dendrite development (GO:2000171) | 2.61316614 |
| 180 | cAMP metabolic process (GO:0046058) | 2.60366701 |
| 181 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.59890163 |
| 182 | opioid receptor signaling pathway (GO:0038003) | 2.59700244 |
| 183 | synaptic vesicle maturation (GO:0016188) | 2.59488262 |
| 184 | multicellular organismal reproductive behavior (GO:0033057) | 2.59073083 |
| 185 | locomotory exploration behavior (GO:0035641) | 2.58208840 |
| 186 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.57740003 |
| 187 | regulation of amino acid transport (GO:0051955) | 2.56480999 |
| 188 | fear response (GO:0042596) | 2.55974168 |
| 189 | tachykinin receptor signaling pathway (GO:0007217) | 2.55766551 |
| 190 | membrane hyperpolarization (GO:0060081) | 2.54322695 |
| 191 | synapse assembly (GO:0007416) | 2.54110220 |
| 192 | reflex (GO:0060004) | 2.53605095 |
| 193 | negative regulation of amino acid transport (GO:0051956) | 2.53237968 |
| 194 | dendritic spine morphogenesis (GO:0060997) | 2.50995744 |
| 195 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.50994697 |
| 196 | neuronal action potential propagation (GO:0019227) | 2.50703667 |
| 197 | negative regulation of neurotransmitter transport (GO:0051589) | 2.50565250 |
| 198 | dopamine receptor signaling pathway (GO:0007212) | 2.50540138 |
| 199 | B cell receptor signaling pathway (GO:0050853) | 10.8495755 |
| 200 | germinal center formation (GO:0002467) | 10.1207653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 7.19200409 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.76776375 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.10512776 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.85225062 |
| 5 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 4.69112284 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.97077697 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.66376355 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.55558197 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.48995700 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.33161707 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.31388995 |
| 12 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.18150419 |
| 13 | CIITA_25753668_ChIP-Seq_RAJI_Human | 3.15362872 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.05718305 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88053800 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.77866948 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77216933 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76508736 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.62031813 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50860177 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.46169182 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45400312 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42958412 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42958412 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.42827117 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40907315 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40736355 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.33417574 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 2.32902622 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.31497856 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.30066342 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.25899293 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24033212 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.22554987 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17918262 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.16883926 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14817757 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.13311375 |
| 39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08834598 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 2.07225514 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05089736 |
| 42 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02608435 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02486801 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.02035015 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.01848698 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01300068 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00833613 |
| 48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 2.00051935 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.99016695 |
| 50 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.93663297 |
| 51 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.87551450 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87499299 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.87119077 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86417792 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84623507 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.83415674 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81299651 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80345056 |
| 59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76871304 |
| 60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75070862 |
| 61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.74656185 |
| 62 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.67892150 |
| 63 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.66724312 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.64897031 |
| 65 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.62900893 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61579475 |
| 67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60443100 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59779886 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58547778 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.57448755 |
| 71 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56243162 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55611972 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55600533 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53414990 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51737769 |
| 76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51641351 |
| 77 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51188743 |
| 78 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50164410 |
| 79 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48052787 |
| 80 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47919063 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47585565 |
| 82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46313143 |
| 83 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43259709 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42898539 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.41878724 |
| 86 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40791141 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.39255387 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38859225 |
| 89 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37788195 |
| 90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36993524 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.36450435 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35721968 |
| 93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33080530 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31648716 |
| 95 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31336285 |
| 96 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31199922 |
| 97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29797372 |
| 98 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28830732 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27769463 |
| 100 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26651469 |
| 101 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.26539816 |
| 102 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25747398 |
| 103 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23932242 |
| 104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23929679 |
| 105 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22710044 |
| 106 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22413998 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22105192 |
| 108 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21058434 |
| 109 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20674672 |
| 110 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.20665284 |
| 111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20496691 |
| 112 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20000226 |
| 113 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19398529 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19186229 |
| 115 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16864912 |
| 116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16712541 |
| 117 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16245562 |
| 118 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16051339 |
| 119 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15441606 |
| 120 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14779758 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14754838 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14520152 |
| 123 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14282519 |
| 124 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.13670562 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13424054 |
| 126 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13388410 |
| 127 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12524339 |
| 128 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12524092 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12405012 |
| 130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12140296 |
| 131 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12098375 |
| 132 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11651619 |
| 133 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11153632 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10695403 |
| 135 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10636087 |
| 136 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10299554 |
| 137 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10076551 |
| 138 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09731845 |
| 139 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.09644136 |
| 140 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09644136 |
| 141 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09236212 |
| 142 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.09203473 |
| 143 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08844152 |
| 144 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07398394 |
| 145 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06950776 |
| 146 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06642264 |
| 147 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.05621943 |
| 148 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.05173239 |
| 149 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04108998 |
| 150 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03703414 |
| 151 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03607013 |
| 152 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02988660 |
| 153 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02248555 |
| 154 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.01770906 |
| 155 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01597929 |
| 156 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01438288 |
| 157 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00589451 |
| 158 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00539155 |
| 159 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00432820 |
| 160 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00257282 |
| 161 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99394728 |
| 162 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98867832 |
| 163 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.98801591 |
| 164 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98385068 |
| 165 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97735508 |
| 166 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97427579 |
| 167 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96924135 |
| 168 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95688568 |
| 169 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.92914025 |
| 170 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92880038 |
| 171 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88042833 |
| 172 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87196075 |
| 173 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.85856046 |
| 174 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84696681 |
| 175 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83197059 |
| 176 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81712144 |
| 177 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.81635481 |
| 178 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81111471 |
| 179 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78923858 |
| 180 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78843773 |
| 181 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78283933 |
| 182 | P300_27268052_Chip-Seq_Bcells_Human | 0.78265464 |
| 183 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.77871504 |
| 184 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.75200228 |
| 185 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.73872214 |
| 186 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72869491 |
| 187 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.70428472 |
| 188 | GATA3_26560356_Chip-Seq_TH1_Human | 0.69147584 |
| 189 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.69049036 |
| 190 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68988585 |
| 191 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67267082 |
| 192 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.66908299 |
| 193 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.66336908 |
| 194 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66238538 |
| 195 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65961627 |
| 196 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.65771531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 5.38089332 |
| 2 | MP0001800_abnormal_humoral_immune | 4.60921025 |
| 3 | MP0005387_immune_system_phenotype | 4.39183959 |
| 4 | MP0001790_abnormal_immune_system | 4.39183959 |
| 5 | MP0001835_abnormal_antigen_presentation | 4.23410466 |
| 6 | MP0000685_abnormal_immune_system | 3.97113446 |
| 7 | MP0003880_abnormal_central_pattern | 3.96930200 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.85826184 |
| 9 | MP0003763_abnormal_thymus_physiology | 3.82498595 |
| 10 | MP0006292_abnormal_olfactory_placode | 3.65688829 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 3.36860022 |
| 12 | MP0002452_abnormal_antigen_presenting | 3.33818614 |
| 13 | MP0001486_abnormal_startle_reflex | 3.15095143 |
| 14 | MP0008057_abnormal_DNA_replication | 3.07882950 |
| 15 | MP0001188_hyperpigmentation | 3.06201194 |
| 16 | MP0009745_abnormal_behavioral_response | 3.02367797 |
| 17 | MP0002723_abnormal_immune_serum | 2.79082902 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.75598445 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.74058210 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 2.72401901 |
| 21 | MP0002398_abnormal_bone_marrow | 2.68929644 |
| 22 | MP0000013_abnormal_adipose_tissue | 2.68692570 |
| 23 | MP0003303_peritoneal_inflammation | 2.66077057 |
| 24 | MP0000537_abnormal_urethra_morphology | 2.65026165 |
| 25 | MP0002063_abnormal_learning/memory/cond | 2.55569889 |
| 26 | MP0003436_decreased_susceptibility_to | 2.54372600 |
| 27 | MP0001819_abnormal_immune_cell | 2.50938444 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.44923657 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 2.43547201 |
| 30 | MP0002254_reproductive_system_inflammat | 2.40462468 |
| 31 | MP0009046_muscle_twitch | 2.38168311 |
| 32 | MP0000716_abnormal_immune_system | 2.32913110 |
| 33 | MP0001984_abnormal_olfaction | 2.28975405 |
| 34 | MP0002064_seizures | 2.26673376 |
| 35 | MP0005499_abnormal_olfactory_system | 2.24226201 |
| 36 | MP0005394_taste/olfaction_phenotype | 2.24226201 |
| 37 | MP0001529_abnormal_vocalization | 2.16937874 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 2.13625455 |
| 39 | MP0001501_abnormal_sleep_pattern | 2.10254752 |
| 40 | MP0005423_abnormal_somatic_nervous | 2.07121336 |
| 41 | MP0002272_abnormal_nervous_system | 2.03487526 |
| 42 | MP0002722_abnormal_immune_system | 1.99277625 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.95923801 |
| 44 | MP0010094_abnormal_chromosome_stability | 1.93521234 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.85731301 |
| 46 | MP0002429_abnormal_blood_cell | 1.82731302 |
| 47 | MP0004381_abnormal_hair_follicle | 1.80438527 |
| 48 | MP0005025_abnormal_response_to | 1.77231040 |
| 49 | MP0008004_abnormal_stomach_pH | 1.74166380 |
| 50 | MP0003136_yellow_coat_color | 1.72840915 |
| 51 | MP0009785_altered_susceptibility_to | 1.70408537 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.68034903 |
| 53 | MP0002405_respiratory_system_inflammati | 1.67627293 |
| 54 | MP0001853_heart_inflammation | 1.65760457 |
| 55 | MP0005671_abnormal_response_to | 1.64736026 |
| 56 | MP0002736_abnormal_nociception_after | 1.62127421 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.61931288 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.58751292 |
| 59 | MP0003111_abnormal_nucleus_morphology | 1.57715517 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.57052980 |
| 61 | MP0003787_abnormal_imprinting | 1.55582353 |
| 62 | MP0002735_abnormal_chemical_nociception | 1.52536755 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.49661660 |
| 64 | MP0003693_abnormal_embryo_hatching | 1.49342180 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.48603731 |
| 66 | MP0002876_abnormal_thyroid_physiology | 1.48456925 |
| 67 | MP0003077_abnormal_cell_cycle | 1.46851766 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.46798441 |
| 69 | MP0004270_analgesia | 1.46004542 |
| 70 | MP0002734_abnormal_mechanical_nocicepti | 1.44514199 |
| 71 | MP0005409_darkened_coat_color | 1.44395680 |
| 72 | MP0005451_abnormal_body_composition | 1.44208621 |
| 73 | MP0001905_abnormal_dopamine_level | 1.44155727 |
| 74 | MP0005248_abnormal_Harderian_gland | 1.43479617 |
| 75 | MP0001440_abnormal_grooming_behavior | 1.40437092 |
| 76 | MP0006276_abnormal_autonomic_nervous | 1.40154185 |
| 77 | MP0002638_abnormal_pupillary_reflex | 1.39459162 |
| 78 | MP0001502_abnormal_circadian_rhythm | 1.38085142 |
| 79 | MP0004142_abnormal_muscle_tone | 1.34318586 |
| 80 | MP0005171_absent_coat_pigmentation | 1.34104777 |
| 81 | MP0001970_abnormal_pain_threshold | 1.33976290 |
| 82 | MP0002184_abnormal_innervation | 1.32979058 |
| 83 | MP0002009_preneoplasia | 1.30965572 |
| 84 | MP0003300_gastrointestinal_ulcer | 1.28959243 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 1.28797733 |
| 86 | MP0004858_abnormal_nervous_system | 1.28410707 |
| 87 | MP0002419_abnormal_innate_immunity | 1.28155031 |
| 88 | MP0002166_altered_tumor_susceptibility | 1.26297059 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 1.25274090 |
| 90 | MP0003122_maternal_imprinting | 1.24631002 |
| 91 | MP0001346_abnormal_lacrimal_gland | 1.24203610 |
| 92 | MP0010234_abnormal_vibrissa_follicle | 1.23423184 |
| 93 | MP0000778_abnormal_nervous_system | 1.23316663 |
| 94 | MP0000003_abnormal_adipose_tissue | 1.22790062 |
| 95 | MP0008995_early_reproductive_senescence | 1.19525136 |
| 96 | MP0005464_abnormal_platelet_physiology | 1.19497274 |
| 97 | MP0000566_synostosis | 1.19231177 |
| 98 | MP0003011_delayed_dark_adaptation | 1.17443091 |
| 99 | MP0002019_abnormal_tumor_incidence | 1.17064784 |
| 100 | MP0004947_skin_inflammation | 1.17043928 |
| 101 | MP0002733_abnormal_thermal_nociception | 1.14113753 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 1.11568854 |
| 103 | MP0004742_abnormal_vestibular_system | 1.10129258 |
| 104 | MP0002136_abnormal_kidney_physiology | 1.07785762 |
| 105 | MP0008872_abnormal_physiological_respon | 1.07662485 |
| 106 | MP0001873_stomach_inflammation | 1.07420997 |
| 107 | MP0003938_abnormal_ear_development | 1.07152881 |
| 108 | MP0010386_abnormal_urinary_bladder | 1.06248837 |
| 109 | MP0010155_abnormal_intestine_physiology | 1.05201626 |
| 110 | MP0005257_abnormal_intraocular_pressure | 1.05070049 |
| 111 | MP0000026_abnormal_inner_ear | 1.04657382 |
| 112 | MP0001986_abnormal_taste_sensitivity | 1.04408711 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 1.04247944 |
| 114 | MP0003091_abnormal_cell_migration | 1.03891469 |
| 115 | MP0003890_abnormal_embryonic-extraembry | 1.02737455 |
| 116 | MP0000762_abnormal_tongue_morphology | 1.02488256 |
| 117 | MP0008789_abnormal_olfactory_epithelium | 1.02182880 |
| 118 | MP0002006_tumorigenesis | 0.99027340 |
| 119 | MP0001963_abnormal_hearing_physiology | 0.98371865 |
| 120 | MP0002752_abnormal_somatic_nervous | 0.97975776 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.97946262 |
| 122 | MP0005386_behavior/neurological_phenoty | 0.97873458 |
| 123 | MP0004924_abnormal_behavior | 0.97873458 |
| 124 | MP0004036_abnormal_muscle_relaxation | 0.97597858 |
| 125 | MP0002102_abnormal_ear_morphology | 0.96807833 |
| 126 | MP0000350_abnormal_cell_proliferation | 0.95871620 |
| 127 | MP0000955_abnormal_spinal_cord | 0.94416360 |
| 128 | MP0002882_abnormal_neuron_morphology | 0.93444908 |
| 129 | MP0000538_abnormal_urinary_bladder | 0.93175792 |
| 130 | MP0003137_abnormal_impulse_conducting | 0.92386306 |
| 131 | MP0002909_abnormal_adrenal_gland | 0.90959679 |
| 132 | MP0003879_abnormal_hair_cell | 0.90905972 |
| 133 | MP0004085_abnormal_heartbeat | 0.89649246 |
| 134 | MP0000313_abnormal_cell_death | 0.89463592 |
| 135 | MP0000015_abnormal_ear_pigmentation | 0.89231967 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.87361667 |
| 137 | MP0002066_abnormal_motor_capabilities/c | 0.86848027 |
| 138 | MP0005166_decreased_susceptibility_to | 0.86748379 |
| 139 | MP0000249_abnormal_blood_vessel | 0.86580332 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.86326215 |
| 141 | MP0000678_abnormal_parathyroid_gland | 0.85741759 |
| 142 | MP0005310_abnormal_salivary_gland | 0.83855454 |
| 143 | MP0009697_abnormal_copulation | 0.83816422 |
| 144 | MP0004885_abnormal_endolymph | 0.83709041 |
| 145 | MP0010307_abnormal_tumor_latency | 0.81055541 |
| 146 | MP0003690_abnormal_glial_cell | 0.79420797 |
| 147 | MP0008569_lethality_at_weaning | 0.79152130 |
| 148 | MP0002127_abnormal_cardiovascular_syste | 0.78977964 |
| 149 | MP0010678_abnormal_skin_adnexa | 0.78954365 |
| 150 | MP0004957_abnormal_blastocyst_morpholog | 0.78165137 |
| 151 | MP0000049_abnormal_middle_ear | 0.77903360 |
| 152 | MP0003866_abnormal_defecation | 0.76925120 |
| 153 | MP0005253_abnormal_eye_physiology | 0.76298070 |
| 154 | MP0003183_abnormal_peptide_metabolism | 0.76192550 |
| 155 | MP0002069_abnormal_eating/drinking_beha | 0.75909416 |
| 156 | MP0002877_abnormal_melanocyte_morpholog | 0.75225529 |
| 157 | MP0001177_atelectasis | 0.75137720 |
| 158 | MP0008469_abnormal_protein_level | 0.73964427 |
| 159 | MP0000920_abnormal_myelination | 0.73675909 |
| 160 | MP0002933_joint_inflammation | 0.73050406 |
| 161 | MP0002090_abnormal_vision | 0.72372474 |
| 162 | MP0003941_abnormal_skin_development | 0.71953074 |
| 163 | MP0000383_abnormal_hair_follicle | 0.69543968 |
| 164 | MP0002332_abnormal_exercise_endurance | 0.68609940 |
| 165 | MP0005621_abnormal_cell_physiology | 0.68127479 |
| 166 | MP0008058_abnormal_DNA_repair | 0.67554201 |
| 167 | MP0002132_abnormal_respiratory_system | 0.64654553 |
| 168 | MP0002796_impaired_skin_barrier | 0.64365259 |
| 169 | MP0008874_decreased_physiological_sensi | 0.64262670 |
| 170 | MP0005275_abnormal_skin_tensile | 0.64001343 |
| 171 | MP0003786_premature_aging | 0.62568334 |
| 172 | MP0003566_abnormal_cell_adhesion | 0.62080677 |
| 173 | MP0010352_gastrointestinal_tract_polyps | 0.61884199 |
| 174 | MP0002138_abnormal_hepatobiliary_system | 0.61412896 |
| 175 | MP0001661_extended_life_span | 0.60235028 |
| 176 | MP0005375_adipose_tissue_phenotype | 0.59559682 |
| 177 | MP0002083_premature_death | 0.58599150 |
| 178 | MP0009763_increased_sensitivity_to | 0.57405495 |
| 179 | MP0002095_abnormal_skin_pigmentation | 0.55242319 |
| 180 | MP0003191_abnormal_cellular_cholesterol | 0.54787774 |
| 181 | MP0009764_decreased_sensitivity_to | 0.54787212 |
| 182 | MP0003868_abnormal_feces_composition | 0.54272318 |
| 183 | MP0000490_abnormal_crypts_of | 0.54256479 |
| 184 | MP0001730_embryonic_growth_arrest | 0.52776848 |
| 185 | MP0005501_abnormal_skin_physiology | 0.51528679 |
| 186 | MP0000609_abnormal_liver_physiology | 0.51297733 |
| 187 | MP0000767_abnormal_smooth_muscle | 0.50239955 |
| 188 | MP0000613_abnormal_salivary_gland | 0.49243431 |
| 189 | MP0004084_abnormal_cardiac_muscle | 0.49199275 |
| 190 | MP0004043_abnormal_pH_regulation | 0.47459818 |
| 191 | MP0008007_abnormal_cellular_replicative | 0.46808327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.17283938 |
| 2 | Lymphopenia (HP:0001888) | 6.36902102 |
| 3 | Emphysema (HP:0002097) | 6.24373701 |
| 4 | Focal motor seizures (HP:0011153) | 5.93370746 |
| 5 | Recurrent bronchitis (HP:0002837) | 5.82941351 |
| 6 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 5.58802714 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 5.34586474 |
| 8 | Recurrent sinusitis (HP:0011108) | 5.17539353 |
| 9 | Cellulitis (HP:0100658) | 5.07643361 |
| 10 | IgA deficiency (HP:0002720) | 5.07349633 |
| 11 | Febrile seizures (HP:0002373) | 5.04967639 |
| 12 | Meningitis (HP:0001287) | 4.79531162 |
| 13 | Colitis (HP:0002583) | 4.78565626 |
| 14 | Papilloma (HP:0012740) | 4.72575164 |
| 15 | Verrucae (HP:0200043) | 4.72575164 |
| 16 | Vasculitis (HP:0002633) | 4.60235193 |
| 17 | Hyperventilation (HP:0002883) | 4.56107333 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.52844236 |
| 19 | Viral hepatitis (HP:0006562) | 4.35541804 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 4.35248011 |
| 21 | Restrictive lung disease (HP:0002091) | 4.23707219 |
| 22 | Recurrent viral infections (HP:0004429) | 4.14045185 |
| 23 | Epileptic encephalopathy (HP:0200134) | 4.10810468 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 3.95618394 |
| 25 | Hypoplasia of the thymus (HP:0000778) | 3.95602876 |
| 26 | Lymphoma (HP:0002665) | 3.90836935 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.89136287 |
| 28 | Myokymia (HP:0002411) | 3.88236013 |
| 29 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.81970255 |
| 30 | Bilateral microphthalmos (HP:0007633) | 3.72389806 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.71248388 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.71248388 |
| 33 | Chronic sinusitis (HP:0011109) | 3.69769211 |
| 34 | Chronic diarrhea (HP:0002028) | 3.67953031 |
| 35 | Osteomyelitis (HP:0002754) | 3.58663309 |
| 36 | Focal seizures (HP:0007359) | 3.55359916 |
| 37 | Recurrent lower respiratory tract infections (HP:0002783) | 3.47418826 |
| 38 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.42812995 |
| 39 | Hypoplasia of the fovea (HP:0007750) | 3.42812995 |
| 40 | Leukopenia (HP:0001882) | 3.42001453 |
| 41 | Encephalitis (HP:0002383) | 3.34150786 |
| 42 | Anomalous pulmonary venous return (HP:0010772) | 3.30437312 |
| 43 | Abnormality of the prostate (HP:0008775) | 3.19639348 |
| 44 | Chronic otitis media (HP:0000389) | 3.19196725 |
| 45 | Bronchitis (HP:0012387) | 3.12795595 |
| 46 | IgM deficiency (HP:0002850) | 3.10050932 |
| 47 | Recurrent otitis media (HP:0000403) | 3.04531951 |
| 48 | IgG deficiency (HP:0004315) | 3.02619642 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.97894353 |
| 50 | Chromsome breakage (HP:0040012) | 2.93282867 |
| 51 | Abnormality of the pulmonary veins (HP:0011718) | 2.92569206 |
| 52 | Recurrent pneumonia (HP:0006532) | 2.92356831 |
| 53 | Absent/shortened dynein arms (HP:0200106) | 2.87704102 |
| 54 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.87704102 |
| 55 | Impulsivity (HP:0100710) | 2.83238665 |
| 56 | Sepsis (HP:0100806) | 2.78470062 |
| 57 | Abnormal ciliary motility (HP:0012262) | 2.70316216 |
| 58 | Dialeptic seizures (HP:0011146) | 2.65763650 |
| 59 | Limb hypertonia (HP:0002509) | 2.65573414 |
| 60 | Recurrent fungal infections (HP:0002841) | 2.62938506 |
| 61 | Septo-optic dysplasia (HP:0100842) | 2.60300761 |
| 62 | Abnormality of the peritoneum (HP:0002585) | 2.59842202 |
| 63 | Hepatoblastoma (HP:0002884) | 2.57521104 |
| 64 | Bile duct proliferation (HP:0001408) | 2.56807595 |
| 65 | Abnormal biliary tract physiology (HP:0012439) | 2.56807595 |
| 66 | Abnormality of the fovea (HP:0000493) | 2.56010753 |
| 67 | Generalized tonic-clonic seizures (HP:0002069) | 2.55363120 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.51532589 |
| 69 | Abnormality of T cells (HP:0002843) | 2.50923582 |
| 70 | Broad-based gait (HP:0002136) | 2.49828201 |
| 71 | Villous atrophy (HP:0011473) | 2.49139466 |
| 72 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.49139466 |
| 73 | Hemiparesis (HP:0001269) | 2.46878906 |
| 74 | Amblyopia (HP:0000646) | 2.45084640 |
| 75 | Pendular nystagmus (HP:0012043) | 2.44442758 |
| 76 | Duplication of thumb phalanx (HP:0009942) | 2.42260237 |
| 77 | Increased IgE level (HP:0003212) | 2.42025163 |
| 78 | Atonic seizures (HP:0010819) | 2.37334147 |
| 79 | Protruding tongue (HP:0010808) | 2.36438835 |
| 80 | Hepatitis (HP:0012115) | 2.35651832 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.33687431 |
| 82 | T lymphocytopenia (HP:0005403) | 2.33469934 |
| 83 | White forelock (HP:0002211) | 2.32153000 |
| 84 | Reduced antithrombin III activity (HP:0001976) | 2.31976929 |
| 85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25704979 |
| 86 | Decreased central vision (HP:0007663) | 2.24417723 |
| 87 | Recurrent skin infections (HP:0001581) | 2.21828160 |
| 88 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.21466120 |
| 89 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.20283142 |
| 90 | 3-Methylglutaconic aciduria (HP:0003535) | 2.19899592 |
| 91 | Partial duplication of thumb phalanx (HP:0009944) | 2.18567885 |
| 92 | Osteomalacia (HP:0002749) | 2.18546211 |
| 93 | Upper limb muscle weakness (HP:0003484) | 2.18190892 |
| 94 | Embryonal renal neoplasm (HP:0011794) | 2.17465117 |
| 95 | Parakeratosis (HP:0001036) | 2.15826218 |
| 96 | Atelectasis (HP:0100750) | 2.14809200 |
| 97 | Abnormality of male internal genitalia (HP:0000022) | 2.12679576 |
| 98 | Preauricular pit (HP:0004467) | 2.10496879 |
| 99 | Periauricular skin pits (HP:0100277) | 2.10496879 |
| 100 | Congenital stationary night blindness (HP:0007642) | 2.10252219 |
| 101 | Medial flaring of the eyebrow (HP:0010747) | 2.10107245 |
| 102 | Deep palmar crease (HP:0006191) | 2.09224731 |
| 103 | Skin rash (HP:0000988) | 2.08469439 |
| 104 | Recurrent bacterial skin infections (HP:0005406) | 2.06941645 |
| 105 | Chronic hepatic failure (HP:0100626) | 2.06090140 |
| 106 | Poikiloderma (HP:0001029) | 2.04232540 |
| 107 | Gaze-evoked nystagmus (HP:0000640) | 2.04150403 |
| 108 | Absent speech (HP:0001344) | 2.03041955 |
| 109 | Lymphedema (HP:0001004) | 2.02802620 |
| 110 | Absence seizures (HP:0002121) | 2.01812468 |
| 111 | Microvesicular hepatic steatosis (HP:0001414) | 2.00375704 |
| 112 | Gastrointestinal stroma tumor (HP:0100723) | 11.0423210 |
| 113 | Patchy hypopigmentation of hair (HP:0011365) | 1.99909377 |
| 114 | Dysdiadochokinesis (HP:0002075) | 1.99219482 |
| 115 | Abnormality of the pleura (HP:0002103) | 1.99135005 |
| 116 | Cutaneous melanoma (HP:0012056) | 1.98787423 |
| 117 | Medulloblastoma (HP:0002885) | 1.96813703 |
| 118 | Obstructive lung disease (HP:0006536) | 1.96171607 |
| 119 | Chronic obstructive pulmonary disease (HP:0006510) | 1.96171607 |
| 120 | Anophthalmia (HP:0000528) | 1.96083586 |
| 121 | Sensory axonal neuropathy (HP:0003390) | 1.95432014 |
| 122 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.95207858 |
| 123 | Optic nerve hypoplasia (HP:0000609) | 1.94740467 |
| 124 | Abnormality of T cell number (HP:0011839) | 1.94298684 |
| 125 | Nasolacrimal duct obstruction (HP:0000579) | 1.93031564 |
| 126 | Blue irides (HP:0000635) | 1.92577527 |
| 127 | Horizontal nystagmus (HP:0000666) | 1.90952095 |
| 128 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.90717815 |
| 129 | Inability to walk (HP:0002540) | 1.89760599 |
| 130 | Basal cell carcinoma (HP:0002671) | 1.89347304 |
| 131 | Fetal akinesia sequence (HP:0001989) | 1.87336953 |
| 132 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.87079491 |
| 133 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.87079491 |
| 134 | Deeply set eye (HP:0000490) | 1.87006128 |
| 135 | Supernumerary spleens (HP:0009799) | 1.87002600 |
| 136 | Squamous cell carcinoma (HP:0002860) | 1.86440876 |
| 137 | Abnormality of the lacrimal duct (HP:0011481) | 1.86343433 |
| 138 | Annular pancreas (HP:0001734) | 1.85717588 |
| 139 | Dyschromatopsia (HP:0007641) | 1.84412676 |
| 140 | Fair hair (HP:0002286) | 1.84294525 |
| 141 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.84264589 |
| 142 | Gait imbalance (HP:0002141) | 1.83535626 |
| 143 | Torticollis (HP:0000473) | 1.83450413 |
| 144 | Abnormality of chromosome stability (HP:0003220) | 1.80604977 |
| 145 | Neutropenia (HP:0001875) | 1.79594205 |
| 146 | Distal lower limb amyotrophy (HP:0008944) | 1.79430484 |
| 147 | Generalized hypopigmentation of hair (HP:0011358) | 1.79049977 |
| 148 | Abnormal foot bone ossification (HP:0010675) | 1.78856395 |
| 149 | Status epilepticus (HP:0002133) | 1.78845853 |
| 150 | Tented upper lip vermilion (HP:0010804) | 1.77916535 |
| 151 | Split foot (HP:0001839) | 1.77403491 |
| 152 | Rhabdomyosarcoma (HP:0002859) | 1.77215186 |
| 153 | Recurrent abscess formation (HP:0002722) | 1.76279684 |
| 154 | Progressive external ophthalmoplegia (HP:0000590) | 1.75768323 |
| 155 | Cheilitis (HP:0100825) | 1.75034707 |
| 156 | Aplasia cutis congenita (HP:0001057) | 1.74775932 |
| 157 | Congenital primary aphakia (HP:0007707) | 1.74761214 |
| 158 | Scanning speech (HP:0002168) | 1.74099394 |
| 159 | Abnormal EKG (HP:0003115) | 1.74037776 |
| 160 | Skin ulcer (HP:0200042) | 1.73817933 |
| 161 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73681991 |
| 162 | Abnormality of the thymus (HP:0000777) | 1.72663815 |
| 163 | Arthralgia (HP:0002829) | 1.72304673 |
| 164 | Abnormality of the fingertips (HP:0001211) | 1.70395730 |
| 165 | Iris hypopigmentation (HP:0007730) | 1.69168091 |
| 166 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.68587669 |
| 167 | Elevated hepatic transaminases (HP:0002910) | 1.68310535 |
| 168 | Abnormality of the pupil (HP:0000615) | 1.67458034 |
| 169 | Pili torti (HP:0003777) | 1.66799345 |
| 170 | Limb dystonia (HP:0002451) | 1.66599128 |
| 171 | Congenital sensorineural hearing impairment (HP:0008527) | 1.66160655 |
| 172 | Stereotypic behavior (HP:0000733) | 1.65947602 |
| 173 | Type I transferrin isoform profile (HP:0003642) | 1.64813604 |
| 174 | Increased IgM level (HP:0003496) | 1.64044792 |
| 175 | Cafe-au-lait spot (HP:0000957) | 1.63876847 |
| 176 | Reticulocytopenia (HP:0001896) | 1.63325703 |
| 177 | Exotropia (HP:0000577) | 1.63182676 |
| 178 | Rib fusion (HP:0000902) | 1.63126156 |
| 179 | Chest pain (HP:0100749) | 1.63059517 |
| 180 | Corneal erosion (HP:0200020) | 1.62350386 |
| 181 | Partial duplication of the phalanx of hand (HP:0009999) | 1.62206016 |
| 182 | Congenital hepatic fibrosis (HP:0002612) | 1.62161276 |
| 183 | Progressive cerebellar ataxia (HP:0002073) | 1.61954900 |
| 184 | Bifid tongue (HP:0010297) | 1.61878608 |
| 185 | Abnormality of DNA repair (HP:0003254) | 1.61397082 |
| 186 | Abnormality of the nasolacrimal system (HP:0000614) | 1.61056937 |
| 187 | Cubitus valgus (HP:0002967) | 1.58622599 |
| 188 | Eczematoid dermatitis (HP:0000976) | 1.57844228 |
| 189 | Slow-growing hair (HP:0002217) | 1.56526789 |
| 190 | Abnormality of hair growth rate (HP:0011363) | 1.56526789 |
| 191 | Follicular hyperkeratosis (HP:0007502) | 1.53750855 |
| 192 | Menstrual irregularities (HP:0000858) | 1.52542539 |
| 193 | Dehydration (HP:0001944) | 1.51314365 |
| 194 | Neoplasm of striated muscle (HP:0009728) | 1.49867584 |
| 195 | Agitation (HP:0000713) | 1.48608131 |
| 196 | Entropion (HP:0000621) | 1.47905146 |
| 197 | Abnormality of chromosome segregation (HP:0002916) | 1.46080660 |
| 198 | Abnormal hair laboratory examination (HP:0003328) | 1.45261283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 8.28148675 |
| 2 | MAP4K1 | 6.10129740 |
| 3 | EPHA4 | 5.46691814 |
| 4 | CASK | 3.81296326 |
| 5 | JAK3 | 3.56593023 |
| 6 | MAP3K10 | 3.32329746 |
| 7 | ADRBK2 | 3.20088971 |
| 8 | PIK3CG | 2.97238665 |
| 9 | NTRK3 | 2.91306017 |
| 10 | ITK | 2.76254889 |
| 11 | BTK | 2.70235779 |
| 12 | TNIK | 2.58647438 |
| 13 | GRK5 | 2.51445737 |
| 14 | SYK | 2.36895274 |
| 15 | PRPF4B | 2.34962773 |
| 16 | GRK1 | 2.32200125 |
| 17 | MST4 | 2.16322818 |
| 18 | TEC | 2.16231558 |
| 19 | NEK9 | 2.10343305 |
| 20 | GRK7 | 1.95481176 |
| 21 | RIPK4 | 1.85867812 |
| 22 | NTRK2 | 1.81313519 |
| 23 | SIK3 | 1.77115766 |
| 24 | MAP2K7 | 1.71674040 |
| 25 | MAP3K13 | 1.67409598 |
| 26 | MAPK7 | 1.67349073 |
| 27 | INSRR | 1.66108218 |
| 28 | MUSK | 1.64207858 |
| 29 | STK39 | 1.56929208 |
| 30 | LYN | 1.52588376 |
| 31 | NEK6 | 1.46634286 |
| 32 | AKT3 | 1.41638471 |
| 33 | BMPR2 | 1.39601706 |
| 34 | TYK2 | 1.37244689 |
| 35 | PINK1 | 1.30060544 |
| 36 | ARAF | 1.27404498 |
| 37 | IKBKE | 1.25135053 |
| 38 | DAPK2 | 1.25053264 |
| 39 | TYRO3 | 1.23089031 |
| 40 | FES | 1.22582438 |
| 41 | TAOK2 | 1.21238155 |
| 42 | SMG1 | 1.19079316 |
| 43 | CDK12 | 1.15685382 |
| 44 | SGK2 | 1.09124594 |
| 45 | MAP2K4 | 1.08410922 |
| 46 | PASK | 1.07261279 |
| 47 | MARK2 | 1.07212901 |
| 48 | TNK2 | 1.06942672 |
| 49 | SIK2 | 1.06734262 |
| 50 | NTRK1 | 1.05808871 |
| 51 | SGK494 | 1.05452506 |
| 52 | SGK223 | 1.05452506 |
| 53 | GRK6 | 1.02217044 |
| 54 | MAP3K14 | 1.01691539 |
| 55 | CAMK4 | 1.01171260 |
| 56 | PKN1 | 1.00964311 |
| 57 | CDK4 | 1.00135011 |
| 58 | WNK1 | 0.90079890 |
| 59 | BCR | 0.89513973 |
| 60 | LCK | 0.87817919 |
| 61 | MAPK13 | 0.87567817 |
| 62 | PRKCG | 0.87434866 |
| 63 | MARK1 | 0.86651009 |
| 64 | MATK | 0.86214512 |
| 65 | IRAK4 | 0.86096615 |
| 66 | YES1 | 0.84181960 |
| 67 | PRKCE | 0.83139351 |
| 68 | MAPK11 | 0.82193479 |
| 69 | CDK5 | 0.81390386 |
| 70 | STK10 | 0.80840429 |
| 71 | LRRK2 | 0.80797608 |
| 72 | CAMK2A | 0.80297746 |
| 73 | EIF2AK2 | 0.80074817 |
| 74 | ZAK | 0.78821011 |
| 75 | MAP2K6 | 0.76990078 |
| 76 | KSR1 | 0.76886619 |
| 77 | IRAK2 | 0.76870684 |
| 78 | CAMK1G | 0.76599771 |
| 79 | PRKD2 | 0.75458359 |
| 80 | TESK2 | 0.75277845 |
| 81 | ADRBK1 | 0.74989360 |
| 82 | IRAK3 | 0.74658656 |
| 83 | SCYL2 | 0.74132870 |
| 84 | EEF2K | 0.74009567 |
| 85 | TXK | 0.73747382 |
| 86 | TRIB3 | 0.72972425 |
| 87 | MAP3K12 | 0.72502849 |
| 88 | BRAF | 0.72475437 |
| 89 | BRD4 | 0.71613539 |
| 90 | CAMK1 | 0.71242122 |
| 91 | IKBKB | 0.71171792 |
| 92 | CAMKK2 | 0.69834334 |
| 93 | PLK2 | 0.69359453 |
| 94 | MINK1 | 0.69043636 |
| 95 | EIF2AK3 | 0.68639698 |
| 96 | MAP3K4 | 0.68628209 |
| 97 | BRSK2 | 0.68524419 |
| 98 | MAP3K9 | 0.66834604 |
| 99 | MOS | 0.66526702 |
| 100 | MAP2K3 | 0.66025842 |
| 101 | CAMK1D | 0.65177041 |
| 102 | SGK1 | 0.65166835 |
| 103 | JAK1 | 0.65050252 |
| 104 | OXSR1 | 0.64973648 |
| 105 | BLK | 0.63422685 |
| 106 | FGFR4 | 0.62183003 |
| 107 | PDK1 | 0.61698389 |
| 108 | DYRK1A | 0.58997672 |
| 109 | ABL1 | 0.58997011 |
| 110 | MAP2K2 | 0.58932503 |
| 111 | OBSCN | 0.58227438 |
| 112 | PRKACA | 0.56750602 |
| 113 | PRKCH | 0.56641033 |
| 114 | HCK | 0.56339303 |
| 115 | CDK3 | 0.55956115 |
| 116 | CAMK2B | 0.55139469 |
| 117 | KIT | 0.55109451 |
| 118 | TAF1 | 0.54539367 |
| 119 | SGK3 | 0.53794260 |
| 120 | RPS6KA4 | 0.51055063 |
| 121 | NEK2 | 0.49901196 |
| 122 | MAPK12 | 0.49822715 |
| 123 | STK38 | 0.48890877 |
| 124 | PRKCQ | 0.47870890 |
| 125 | CDC42BPA | 0.46327313 |
| 126 | PAK6 | 0.44859816 |
| 127 | ATR | 0.44357810 |
| 128 | INSR | 0.44239724 |
| 129 | CLK1 | 0.43259063 |
| 130 | CDK8 | 0.42869808 |
| 131 | BMPR1B | 0.42339227 |
| 132 | PRKG1 | 0.42302787 |
| 133 | MAP3K7 | 0.41899760 |
| 134 | FYN | 0.41805794 |
| 135 | MAP3K1 | 0.41669884 |
| 136 | CAMKK1 | 0.41467121 |
| 137 | PNCK | 0.40884112 |
| 138 | MAP3K8 | 0.39640647 |
| 139 | MAPK4 | 0.38996122 |
| 140 | PRKCD | 0.38744686 |
| 141 | CDK19 | 0.38063848 |
| 142 | CSF1R | 0.37411087 |
| 143 | EPHA2 | 0.36687467 |
| 144 | IRAK1 | 0.36344711 |
| 145 | TGFBR2 | 0.35439691 |
| 146 | PRKCI | 0.35358180 |
| 147 | CCNB1 | 0.34982664 |
| 148 | SIK1 | 0.34730558 |
| 149 | STK11 | 0.34507633 |
| 150 | CAMK2G | 0.34408016 |
| 151 | PRKG2 | 0.34025785 |
| 152 | CSNK1A1 | 0.33326232 |
| 153 | WNK3 | 0.33161787 |
| 154 | FGR | 0.29314900 |
| 155 | PRKD1 | 0.29209439 |
| 156 | FGFR3 | 0.28121971 |
| 157 | TBK1 | 0.27731640 |
| 158 | CSK | 0.24875944 |
| 159 | KSR2 | 0.24251949 |
| 160 | BUB1 | 0.20421643 |
| 161 | CHUK | 0.20307426 |
| 162 | HIPK2 | 0.19558184 |
| 163 | CDC7 | 0.18582835 |
| 164 | MAP2K1 | 0.17141101 |
| 165 | RPS6KB2 | 0.15464243 |
| 166 | WEE1 | 0.15460688 |
| 167 | CDK9 | 0.13645868 |
| 168 | CHEK1 | 0.13343410 |
| 169 | MARK3 | 0.12963763 |
| 170 | RPS6KC1 | 0.12248077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.88765803 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.52515206 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.83515629 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.70762898 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 3.02639842 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.96666317 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.89369936 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.79463264 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61672831 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.54361461 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.54063651 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.42995075 |
| 13 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.41408657 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.38610521 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.34967680 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.33028722 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.26362277 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 2.21226712 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12923743 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 2.12428874 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 2.06837602 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.03936810 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97084261 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.92952863 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.86542828 |
| 26 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.85673629 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.83407064 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.82985041 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78436935 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.68993292 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.65176042 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.65081130 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63406939 |
| 34 | Long-term potentiation_Homo sapiens_hsa04720 | 1.62717349 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.59941326 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.57556897 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.44101871 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.43635970 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40480221 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.37197563 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.36624660 |
| 42 | Insulin secretion_Homo sapiens_hsa04911 | 1.35774077 |
| 43 | Mismatch repair_Homo sapiens_hsa03430 | 1.32611826 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.32397764 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29971920 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.29077899 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28729073 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 1.27423176 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25974371 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 1.24072144 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.23431709 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21781779 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.19422558 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12639300 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11077149 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06346432 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06204763 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05374333 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.05143836 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.04645369 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04184034 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04019810 |
| 63 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03742143 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.03659067 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 1.02039830 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98698454 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93603209 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93348883 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91435722 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90914529 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90471134 |
| 72 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.89941006 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.89180055 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.86945236 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85757213 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84945848 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84737405 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82808392 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81797082 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81281323 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79685954 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77947747 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77805744 |
| 84 | Homologous recombination_Homo sapiens_hsa03440 | 0.76913870 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76289632 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75061473 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.72714030 |
| 88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71841834 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71358400 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.71101357 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.70527439 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70069623 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.68812539 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68234523 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68180938 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67772941 |
| 97 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66954751 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66776063 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.66019627 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65415871 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65045405 |
| 102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63007093 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62444312 |
| 104 | ABC transporters_Homo sapiens_hsa02010 | 0.61045436 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59054955 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58634467 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58270705 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57696935 |
| 109 | Malaria_Homo sapiens_hsa05144 | 0.56611124 |
| 110 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.56255379 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.54814494 |
| 112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54713544 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53827049 |
| 114 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53662011 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53608403 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.52747401 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52527787 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51845805 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51501507 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50548233 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50425481 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49596675 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48894801 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46759680 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45756506 |
| 126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45194187 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.45095723 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44298373 |
| 129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43529184 |
| 130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43527590 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43311511 |
| 132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42001235 |
| 133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41747748 |
| 134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41702907 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39529676 |
| 136 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39445802 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.39317064 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39172878 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38738219 |
| 140 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38616242 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38329996 |
| 142 | Allograft rejection_Homo sapiens_hsa05330 | 0.37709191 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37697384 |
| 144 | Alcoholism_Homo sapiens_hsa05034 | 0.37532881 |
| 145 | Cell cycle_Homo sapiens_hsa04110 | 0.37527440 |
| 146 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36590798 |
| 147 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36194821 |
| 148 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36016959 |
| 149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35283720 |
| 150 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35087955 |
| 151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34532716 |
| 152 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34311950 |
| 153 | Prion diseases_Homo sapiens_hsa05020 | 0.33478211 |
| 154 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.33466454 |
| 155 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32880279 |
| 156 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32118252 |
| 157 | Glioma_Homo sapiens_hsa05214 | 0.31991185 |
| 158 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31839557 |
| 159 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31755184 |
| 160 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31463033 |
| 161 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.30964784 |
| 162 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30879265 |
| 163 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30363832 |
| 164 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.29287679 |
| 165 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.29276841 |
| 166 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28310619 |
| 167 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27240253 |
| 168 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26736048 |
| 169 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26217107 |
| 170 | Melanoma_Homo sapiens_hsa05218 | 0.25890510 |
| 171 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25699905 |
| 172 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.24572290 |
| 173 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.24350696 |
| 174 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23647936 |
| 175 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21375222 |
| 176 | Basal transcription factors_Homo sapiens_hsa03022 | 0.19070009 |
| 177 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.17854954 |
| 178 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.16622145 |

